Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (21587)	6/1/1998 8:18:00 AM
From: Henry Niman	Respond to of 32384

Looks like Forbes was wrong: Pfizer's a Good Candidate to Acquire Monsanto, Forbes Reports Bloomberg News May 29, 1998, 8:32 a.m. PT New York, May 29 (Bloomberg) -- Pfizer Inc.'s a good candidate to buy Monsanto Co., Forbes reported. Monsanto's G.D. Searle drug division is already working with Pfizer to market Searle's new arthritis drugs, the first in of a new type of painkillers with potential sales in the billions of dollars. A Pfizer-Monsanto combination would give Monsanto the cash needed to develop and market those drugs to their fullest potential, and would put Pfizer into agricultural products and seeds, a market in which it's in, the magazine reported. Pfizer said its impotence pill, Viagra, has gained the backing of the expert panel that advises European regulators on drug approvals. (Forbes 6/1 46 www.forbes.com) --Mary Guidry in the Princeton newsroom (609) 279-4028/rmk More News:ÿMTC